You are here: Industry Insights > COVID-19

News List

Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection expresspharma
September 08, 2020
After regulatory approval from AYUSH ministry, the clinical trials are being conducted at HAH Centenary Hospital, New Delhi.
Corticosteroids boost survival rates for COVID-19 patients pharmatimes
September 07, 2020
Four newly-published papers on the use of corticosteroids to treat COVID-19 back prior evidence that outcomes for patients severely affected by the virus can be significantly improved, with one suggesting the risk of death can be cut by up to 20%.
EMA begins review of Dexamethasone Taw for COVID-19 pharmatimes
September 07, 2020
The European Medicines Agency (EMA) has begun evaluating an application for the authorisation of Dexamethasone Taw for treating adults hospitalised with COVID-19.
BreviTest's COVID-19 IgG Antibody Test Receives FDA Commercial Distribution Approval americanpharmaceuticalreview
September 07, 2020
BreviTest Technologies announced the U.S. Food and Drug Administration (FDA) has officially accepted BreviTest's official notification of its intent to commercially distribute its IgG antibody test under policy outlined in Section IV.D. of the Policy ...
CureVac to Receive €252M to Support COVID-19 Vax Development contractpharma
September 07, 2020
The German Federal Ministry of Education and Research grant is also expected to be used for the rapid expansion of vaccine production.
CureVac expects to produce COVID-19 vaccine at scale by year-end expresspharma
September 07, 2020
It is one of a number of firms developing vaccines based on molecules carrying a genetic code called messenger RNA (mRNA) to treat diseases.
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData expresspharma
September 07, 2020
Six of Sanofi’s clinical trials, which were being conducted in 31 countries, have been disrupted, which might impact the company's regulatory decisions.
COVID-19 slashes pharma production in Uttarakhand expresspharma
September 07, 2020
Uttarakhand based pharma companies have seen a decline in pharma production due to the rapid spread of coronavirus in the state.
BDR Pharma to launch 400 mg Favipiravir tablets expresspharma
September 07, 2020
BDR Pharmaceuticals said it plans to launch 400 mg Favipiravir tablets, used for treating COVID-19 patients, in the country.
Vitamin D deficiency may raise risk of getting COVID-19 worldpharmanews
September 04, 2020
In a retrospective study of patients tested for COVID-19, researchers at the University of Chicago Medicine found an association between vitamin D deficiency and the likelihood of becoming infected with the coronavirus.